Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.20 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $127.57 million which missed the analyst consensus estimate of $130.34 million by 2.12 percent. This is a 1.94 percent increase over sales of $125.14 million the same period last year.
Longeveron Provides Corporate Update And Announces 2023 Strategic Priorities And Anticipated Milestones
– Expects to enroll first patient in Phase 2 clinical trial of Lomecel-B™ for Aging-Related Frailty in Japan in 1Q23 –
– Extended cash runway into 2H24 –
MIAMI, Jan. 06, 2023 (GLOBE
